Search
Searching Content indexed under Healthcare by Finnegan, Henderson, Farabow, Garrett & Dunner, LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
FDA Draft Guidance On Early Drug Development And The Role Of Pre-IND Meetings For Rare Diseases
On October 15, 2018, FDA issued draft guidance on Rare Diseases: Early Drug Development and the Role of Pre-IND Meetings.
United States
8 Nov 2018
2
CAFC Affirms PTAB's Priority Determination In Natural Alternatives v. Iancu
In Natural Alternatives International, Inc. v. Iancu., No. 2017-1962 (Fed. Cir. Oct. 1, 2018), the CAFC affirmed the PTAB's priority determination invalidating Natural Alternative's patent directed to a human dietary supplement that increases the anaerobic working capacity of muscle and other tissues.
United States
15 Oct 2018
3
Healthcare Patents Not Immune From Covered Business Method Review
When Congress debated and enacted Section 18 of the AIA, creating "covered business method (CBM) review," healthcare industry patent holders took comfort in the statute's seemingly narrow reach.
United States
14 Oct 2015
4
Trade Dress Protection: Eye Candy
The sweeping competition injected into the industry by generic-drug manufacturers has increased the need for brand-name drugmakers to boost consumer recognition of, and desire for, their branded products.
United States
5 Jun 2009
Links to Result pages
 
1